Lista de obras - Neus Ferrer-Miralles - Dominio Público Uruguay

A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631.

artículo científico publicado en 2003

A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates

artículo científico publicado en 2018

A new bisintercalating anthracycline with picomolar DNA binding affinity.

artículo científico publicado en 2005

A novel bio-functional material based on mammalian cell aggresomes.

artículo científico publicado en 2015

Analysing the contribution of nucleic acids to the structure and properties of centric heterochromatin

artículo científico publicado en 2003

BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.

artículo científico publicado en 2015

Bacterial cell factories for recombinant protein production; expanding the catalogue

artículo científico publicado en 2013

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.

artículo científico publicado en 2016

Biofabrication of functional protein nanoparticles through simple His-tag engineering

artículo científico publicado en 2021

Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine.

artículo científico publicado en 2011

Bottom-Up Instructive Quality Control in the Biofabrication of Smart Protein Materials

artículo científico publicado en 2015

Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy

artículo científico publicado en 2014

Conformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria

artículo científico publicado en 2016

Cross-system excision of chaperone-mediated proteolysis in chaperone-assisted recombinant protein production

artículo científico publicado en 2009

Developing Protein-Antitumoral Drug Nanoconjugates as Bifunctional Antimicrobial Agents

artículo científico publicado en 2020

DnaK/DnaJ-assisted recombinant protein production in Trichoplusia ni larvae.

artículo científico publicado en 2009

Effect of the DnaK chaperone on the conformational quality of JCV VP1 virus-like particles produced in Escherichia coli.

artículo científico publicado en 2014

Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

artículo científico

Engineering RegulableEscherichia coliβ-Galactosidases as Biosensors for Anti-HIV Antibody Detection in Human Sera

artículo científico publicado en 2001

Engineering of Escherichia coli beta-galactosidase for solvent display of a functional scFv antibody fragment

artículo científico publicado en 2003

Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.

artículo científico

Engineering tumor cell targeting in nanoscale amyloidal materials.

artículo científico publicado en 2016

Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors

artículo científico publicado en 2002

Fast electrochemical detection of anti-HIV antibodies: coupling allosteric enzymes and disk microelectrode arrays.

artículo científico publicado en 2009

Functional inclusion bodies produced in the yeast Pichia pastoris.

artículo científico publicado en 2016

Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology

artículo científico publicado en 2016

General introduction: recombinant protein production and purification of insoluble proteins

artículo científico publicado en 2015

Improved performance of protein-based recombinant gene therapy vehicles by tuning downstream procedures

artículo científico publicado en 2013

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics

artículo científico publicado en 2020

In vivo architectonic stability of fully de novo designed protein-only nanoparticles

artículo científico publicado en 2014

Induction of G2/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes

article

Integrated approach to produce a recombinant, His-tagged human α-galactosidase A in mammalian cells.

artículo científico publicado en 2011

Internalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticles.

artículo científico publicado en 2010

Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.

artículo científico publicado en 2012

Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles

artículo científico publicado en 2014

Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery.

artículo científico publicado en 2017

Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles

artículo científico publicado en 2017

Membrane-active peptides for non-viral gene therapy: making the safest easier.

scientific article published on 20 March 2008

Microbial factories for recombinant pharmaceuticals

artículo científico publicado en 2009

Molecular Mechanisms for Antibody-Mediated Modulation of Peptide-Displaying Enzyme Sensors

artículo científico publicado en 2000

Morphological responses to nitrogen stress deficiency of a new heterotrophic isolated strain of Ebro Delta microbial mats

scientific article published on 09 July 2018

Nanoparticulate architecture of protein-based artificial viruses is supported by protein-DNA interactions

artículo científico publicado en 2011

Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles

artículo científico publicado en 2012

Peptide-assisted traffic engineering for nonviral gene therapy.

artículo científico publicado en 2008

Protein aggregation and soluble aggregate formation screened by a fast microdialysis assay

artículo científico publicado en 2010

Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide

artículo científico publicado en 2010

Protein nanoparticles are nontoxic, tuneable cell stressors

artículo científico publicado en 2018

RGD-based cell ligands for cell-targeted drug delivery act as potent trophic factors

artículo científico publicado en 2012

Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles.

artículo científico publicado en 2016

Recombinant Protein-Based Nanoparticles: Elucidating their Inflammatory Effects In Vivo and their Potential as a New Therapeutic Format

artículo científico publicado en 2020

Recombinant pharmaceuticals from microbial cells: a 2015 update

artículo científico publicado en 2016

Recombinant protein materials for bioengineering and nanomedicine.

artículo científico

Rehosting of bacterial chaperones for high-quality protein production.

artículo científico publicado en 2009

Screening HIV-1 antigenic peptides as receptors for antibodies and CD4 in allosteric nanosensors.

artículo científico publicado en 2009

Sheltering DNA in self-organizing, protein-only nano-shells as artificial viruses for gene delivery.

artículo científico publicado en 2013

Side effects of chaperone gene co-expression in recombinant protein production

artículo científico publicado en 2010

Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.

artículo científico publicado en 2015

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.

artículo científico publicado en 2016

Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides.

artículo científico publicado en 2018

The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation

artículo científico publicado en 2010

Tools to cope with difficult-to-express proteins.

artículo científico publicado en 2016

Towards protein-based viral mimetics for cancer therapies.

artículo científico publicado en 2015

Lista de obras de Neus Ferrer-Miralles

A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631.

A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates

A new bisintercalating anthracycline with picomolar DNA binding affinity.

A novel bio-functional material based on mammalian cell aggresomes.

Analysing the contribution of nucleic acids to the structure and properties of centric heterochromatin

BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.

Bacterial cell factories for recombinant protein production; expanding the catalogue

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.

Biofabrication of functional protein nanoparticles through simple His-tag engineering

Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine.

Bottom-Up Instructive Quality Control in the Biofabrication of Smart Protein Materials

Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy

Conformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria

Cross-system excision of chaperone-mediated proteolysis in chaperone-assisted recombinant protein production

Developing Protein-Antitumoral Drug Nanoconjugates as Bifunctional Antimicrobial Agents

DnaK/DnaJ-assisted recombinant protein production in Trichoplusia ni larvae.

Effect of the DnaK chaperone on the conformational quality of JCV VP1 virus-like particles produced in Escherichia coli.

Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Engineering RegulableEscherichia coliβ-Galactosidases as Biosensors for Anti-HIV Antibody Detection in Human Sera

Engineering of Escherichia coli beta-galactosidase for solvent display of a functional scFv antibody fragment

Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.

Engineering tumor cell targeting in nanoscale amyloidal materials.

Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors

Fast electrochemical detection of anti-HIV antibodies: coupling allosteric enzymes and disk microelectrode arrays.

Functional inclusion bodies produced in the yeast Pichia pastoris.

Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology

General introduction: recombinant protein production and purification of insoluble proteins

Improved performance of protein-based recombinant gene therapy vehicles by tuning downstream procedures

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics

In vivo architectonic stability of fully de novo designed protein-only nanoparticles

Induction of G2/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes

Integrated approach to produce a recombinant, His-tagged human α-galactosidase A in mammalian cells.

Internalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticles.

Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.

Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles

Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery.

Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles

Membrane-active peptides for non-viral gene therapy: making the safest easier.

Microbial factories for recombinant pharmaceuticals

Molecular Mechanisms for Antibody-Mediated Modulation of Peptide-Displaying Enzyme Sensors

Morphological responses to nitrogen stress deficiency of a new heterotrophic isolated strain of Ebro Delta microbial mats

Nanoparticulate architecture of protein-based artificial viruses is supported by protein-DNA interactions

Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles

Peptide-assisted traffic engineering for nonviral gene therapy.

Protein aggregation and soluble aggregate formation screened by a fast microdialysis assay

Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide

Protein nanoparticles are nontoxic, tuneable cell stressors

RGD-based cell ligands for cell-targeted drug delivery act as potent trophic factors

Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles.

Recombinant Protein-Based Nanoparticles: Elucidating their Inflammatory Effects In Vivo and their Potential as a New Therapeutic Format

Recombinant pharmaceuticals from microbial cells: a 2015 update

Recombinant protein materials for bioengineering and nanomedicine.

Rehosting of bacterial chaperones for high-quality protein production.

Screening HIV-1 antigenic peptides as receptors for antibodies and CD4 in allosteric nanosensors.

Sheltering DNA in self-organizing, protein-only nano-shells as artificial viruses for gene delivery.

Side effects of chaperone gene co-expression in recombinant protein production

Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.

Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides.

The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation

Tools to cope with difficult-to-express proteins.

Towards protein-based viral mimetics for cancer therapies.